Wikidata

(Q47685354)

English

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

scientific article

In more languages

Statements

title
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
9704735
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9704735%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 December 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q47685354&oldid=1647917063"